A phase Ib/II study to assess the safety and preliminary efficacy of PM8002 in combination with nab-paclitaxel in patients with triple-negative breast cancer
作者全名："Wu, Jiong; Zhang, Jian; Tong, Zhongsheng; Wang, Yongsheng; Zhang, Qingyuan; Cheng, Qiao; Chen, Xin"
作者地址："Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China; Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China; Shandong Canc Hosp & Inst, Jinan, Peoples R China; Harbin Med Univ Canc Hosp, Harbin, Peoples R China; Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; Second Peoples Hosp Yibin, Yibin, Peoples R China"
通信作者：
来源：JOURNAL OF CLINICAL ONCOLOGY
ESI学科分类：CLINICAL MEDICINE
WOS号：WOS:001053772001374
JCR分区：Q1
影响因子：42.1
年份：2023
卷号：41
期号：16
开始页：
结束页：
文献类型：Meeting Abstract
关键词：
摘要：
基金机构：Biotheus Inc.
基金资助正文：Biotheus Inc.
